In breast cancer, patients that experiment an early recurrence (less than 2 years after diagnosis) are related to a more aggressive […]
Tag: #illnesses
RNA signature for the assessment of neoadjuvant chemotherapy response in triple-negative breast cancer
The present invention provides an in vitro method for the prediction of response to neoadjuvant chemotherapy (NAC), or for selecting […]